Pharma Industry
Alembic Pharma Q4 net up 12% to Rs 251 cr on strong API, global businesses
State govts begin vaccine price negotiations, eye Rs 150 per dose
Pharma poised for an excellent FY22 on the back of Covid-led demand
Strong injectables portfolio to support Aurobindo Pharma's growth
Shortage of key chemical hits Bharat Biotech's Covaxin ramp-up plans

Alembic Pharma's injectables plant launch may face some delay
Piramal Pharma to acquire 100% stake in Hemmo Pharma for Rs 775 cr
Orchid Pharma rises from ashes, expects to make profits in 12 months
Govt okays 33 API applications with Rs 5k cr investment under PLI scheme
New launches, market share gains to sustain Gland Pharma's sales trajectory